| Institution | PI Name | Title |
|---|
| AFG Biosolutions, Inc. | Kenneth Alibek | New Generation of Anthrax Prophylaxis and Therapy |
| Alderon Biosciences, Inc. | Robert Kenkens | Electrochemical Quantification of HCV RNA |
| Aridis Pharmaceuticals, LLC | Eric Patzer | Live, oral, heat Stable S. typhi TY21a vaccine |
| Atom Sciences, Inc. | Richard Hurt | Specific Diagnostic for Members of Genus Mycobacterium |
| Avant Immunotherapeutics, Inc. | Kenneth Roland | Live Attenuated Salmonella Vaccine Against Campylobacter |
| AVI Biopharma, Inc. | Patrick Iversen | Antisense Antiviral Agent for West Nile Infections |
| AVI Biopharma, Inc. | Dan Mourich | Apoptotic Regulation of Lymphocyte Responses |
|
| Biohelix Corporation | Huimin Kong | Development of a helicase-based rapid DNA diagnostic system for Biodefense |
| Bioscience Development, Inc. | Steven Schutzer | Detection of Virulent Burkholderia mallei |
|
| Cellex, Inc. | Xing-Xiang Li | A Rapid, Sensitive and Fully Automated Anthrax Test |
| Coda Genomics, LLC | She-Pin Hung | CODA Assembly of Mutant Genes |
|
| Curelab, Inc. | Petr Ilyinskii | Novel broad spectrum vaccination against influenza |
| Embrex, Inc. | John Hebrank | Eliminating Dead Eggs in Flu Vaccine Production |
|
| Epivax, Inc. | Anne De Groot | Novel Smallpox Vaccine Derived from VV/VAR Immunome |
| Fasgen, Inc. | Albert Owens | Treatment of Latent TB and MDR-TB with FAS20013 |
|
| Fractal Systems, Inc. | Anastasia Bogomolova | Electrochemical Multispecific Molecular Detection System |
| Galenea Corporation | Qing Ge | Development of siRNAs to Prevent and Treat Influenza Infection |
|
| Genomic Profiling Systems | Donald Straus | Rapid Clinical Surge-Testing for Biothreat Agents |
| Hawaii Biotech, Inc. | Carolyn Weeks-Levy | Recombinant Subunit Protein for Flu Vaccine |
|
| Howard Shapiro, P.C. | Howard Shapiro | Cytometric Tuberculosis Detection and Sensitivity Tests |
| Immport Therapeutics, Inc. | Philip Felgner | Adjuvants for Agile Vaccine Development |
|
| Inbios International, Inc. | Raymond Houghton | Development of rapid detection tests for Burkholderia pseudomallei |
| Integral Molecular | Benjamin Doranz | Cell-free Biosensor for the Detection of Pathogens |
|
| Intrinsic Bioprobes, Inc. | Randall Nelson | Mass Spectrometry Assays for Biodefense Agents |
| L2 Diagnostics, LLC | Raymond Koski | Protection Against West Nile Virus by RNA Interference |
|
| Life Biomed, LLC | Steven Denkin | Microarray Detection of MDR-TB |
| Luna Innovations, Inc. | Siddhartha De | Validation of a RSK-inhibitor as a NOvel Therapeutic for Yersinia |
|
| Medarex, Inc. | Tibor Keler | An improved targeted vaccine strategy against anthrax |
| Mensanna Research, Inc. | Michael Phillips | Volatile Markers of Pulmonary Tuberculosis in the Breath |
|
| Microbiotix, Inc. | Donald Moir | Sensing Biowarfare Agents by Surface Enhanced Raman |
| Microbiotix, Inc. | Michelle Butler | Development of Screens for Bacillus Anthracis Targets |
|
| Microbiotix, Inc. | Marjorie Barnes | Bacterial DNA Helicases: Targets for Novel Antibiotics |
| Microbiotix, Inc. | Norton Peet | Small Molecule Inhibitors of Anthrax Lethal Factor |
|
| Microcosm, Inc. | Henry Szmacinski | Enhanced Fluorescent Detection of Pathogens |
| Midi, Inc. | Myron Sasser | Rapid Susceptibility Testing of MDR M. tuberculosis |
|
| Najit Technologies, Inc. | Mark Slifka | Rapid Diagnosis of Monkeypox and Smallpox Infections |
| Nexbio, Inc. | Mang Yu | Development of Fludase for Prevention of Influenza |
|
| Novobiotic Pharmaceuticals, LLC | Andrew Staley | Novel Approaches to Accessing Secondary Metabolites |
| Sandra W, LLC | Sandra Woodgate | Multiplex Detection of Microbial Pathogens |
|
| Sciogen, Inc. | Shengqiang Li | Improved Genetically Modified H5N1 Influenza Vaccine |
| Seralogix | Kenneth Drake | Bioinformatics for Immune Response Biosignature Analyses |
|
| Technovax, Inc. | Jose Galarza | Influenza Virus-like Particles As Vaccines |
| Vical, Inc. | Larry Smith | Development of a DNA Vaccine Against Influenza Virus |
|
| Viral Genomix, Inc. | Joseph Kim | Preclinical Test of Biodefense Drug for SEB Toxin |